Effectiveness of mRNA vaccine boosters against infection with the SARS-CoV-2 omicron (B.1.1.529) variant in Spain: a nationwide cohort studySusana Monge, Virgilio Yagüe Galaup, Ayelén Rojas‐Benedicto et al.|The Lancet Infectious Diseases|2022Cited by 84
Effectiveness of Modified Vaccinia Ankara-Bavaria Nordic Vaccination in a Population at High Risk of Mpox: A Spanish Cohort StudyMario Fontán‐Vela, Lucía Fuster Sanjurjo, Nicola Lorusso et al.|Clinical Infectious Diseases|2023Cited by 39
Effectiveness of a Second Dose of an mRNA Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Infection in Individuals Previously Infected by Other VariantsSusana Monge, Virgilio Yagüe Galaup, Ayelén Rojas‐Benedicto et al.|Clinical Infectious Diseases|2022Cited by 9